Guardant Health Inc (GH): Koefisien rega marang pendapatan

Simbol lan logo merek Guardant360 (GH)

Robotic systems and AI automate DNA sequencing at Guardant Health, Inc. (GH), although blood collection remains a manual process. The company's P/S ratio demonstrates business resilience to market shocks, where the value 16.30 expresses the state of the metric. This confirms dominance driven by patent protection and the expansion of Shield tests into clinical practice for early cancer diagnosis.

Kapitalisasi marang pendapatan Guardant Health, Inc. (GH): kanggo periode 04.07.2022 - 13.11.2026

Rincian metrik lan analitis perusahaan Guardant360 (GH)

- rega lan prakiraan konsensus rega:
Bagan bursa guardanthealth.com|GH - Bagan rega target
- data kapitalisasi bursa:
Kapitalisasi pasar Guardant360|GH - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Buku Siji Saham Guardant Health|GH - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku guardanthealth.com|GH - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Guardant Health, Inc.|GH - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Guardant Corp|GH - Gunggung utang perusahaan|Rasio utang marang nilai buku Guardant360|GH - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Guardant Health|Rasio likuiditas darurat guardanthealth.com
- rincian bathi lan kelipatan pasar:
GH - Penghasilan resik|Bathi resik mangsa ngarep Guardant Health, Inc.|GH - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Guardant Health Inc|GH - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Guardant360|GH - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Guardant Health|GH - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan guardanthealth.com|GH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Guardant Health, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
GH - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan guardanthealth.com|GH - Multiplikator P/S|Rega forward marang dodolan Guardant360
Analisis umum perusahaan:guardanthealth.com (GH)
Produk mawa merek Guardant Corp

The P/S multiple determines the market value of a business relative to its annual sales volume, allowing investors to filter out speculative noise and objectively assess the premium paid per unit of revenue. By analyzing the price-to-sales valuation of Guardant Health, Inc. (GH), an investor can correlate the pace of oncology test diversification with capitalization dynamics to timely identify the risk of an overbought asset or potential for growth.

Perusahaan pesaing

Koefisien rega marang pendapatan carislifesciences.com|Rasio rega marang pendapatan Veracyte VCYT|Koefisien rega marang pendapatan Celcuity Inc (CELC)|GRAIL Corp - Multiplikator P/S|Multiplikator rega marang pendapatan Myriad (MYGN)|CSTL (Castle Biosciences) - Kapitalisasi marang pendapatan|brbiotech.com (BNR) - Multiplikator P/S|VNRX (VolitionRx Ltd.) - Multiplikator P/S|Multiplikator P/S Biodesix Inc|Rasio rega marang pendapatan Precipio, Inc (PRPO)|CHEK (check-cap.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MYNZ (Mainz Biomed)|OCX: Rasio kapitalisasi marang pendapatan